Augmentation of high molecular weight kininogen and reduction of kallikrein activity in plasma of L-NAME hypertensive rats.

被引:0
作者
Sendäo, AP [1 ]
Poggi, JC [1 ]
Bendhack, LM [1 ]
Reis, ML [1 ]
机构
[1] Univ Sao Paulo, Coll Pharmaceut Sci Ribeirao Preto, Pharmacol Lab, BR-14040903 Ribeirao Preto, SP, Brazil
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P1515
引用
收藏
页码:R337 / R337
页数:1
相关论文
共 50 条
  • [1] Sympathetic activity is not increased in L-NAME hypertensive rats
    dos Santos, Fernanda Machado
    Martins Dias, Daniel Penteado
    Aguiar da Silva, Carlos Alberto
    Fazan, Rubens, Jr.
    Salgado, Helio Cesar
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2010, 298 (01) : R89 - R95
  • [2] Exercise training induces hemodynamic improvement in L-NAME hypertensive rats.
    De Angelis, KLD
    Ogawa, T
    Gimenes, R
    Farah, VMA
    Cestari, IA
    Irigoyen, MC
    HYPERTENSION, 2001, 37 (03) : 999 - 999
  • [3] Exercise reverses periferic insulin resistance in trained L-NAME hypertensive rats.
    Rigatto, KV
    De Angelis, KLD
    Gadonski, G
    Fang, J
    Dall'Ago, P
    Albuquerque, VL
    Peixoto, LRA
    Fernandes, TG
    Irigoyen, MC
    HYPERTENSION, 1999, 33 (05) : 1309 - 1309
  • [4] Exercise reverses periferic insulin resistance in trained L-NAME hypertensive rats.
    Rigatto, KV
    De Angelis, KLD
    Gadonski, G
    Fang, J
    Dall'Ago, P
    Albuquerque, VL
    Peixoto, LRA
    Fernandes, TG
    Irigoyen, MC
    HYPERTENSION, 1999, 33 (04) : 1089 - 1089
  • [5] Role of cytokines and mononuclear cells in the development of L-NAME induced hypertensive nephrosclerosis in rats.
    Fierlbeck, W
    Fierlbeck, M
    Riess, R
    Geiger, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2391 - A2391
  • [6] Studies on porcine high molecular weight kininogen. An improved method for the purification of porcine high molecular weight kininogen and cleavage of the kininogen by the action of porcine plasma kallikrein
    Mashiko, H
    Miyamoto, K
    Takahashi, H
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1998, 120 (04): : 647 - 656
  • [7] COMPARISON OF HUMAN HIGH-MOLECULAR-WEIGHT KININOGEN DIGESTION BY PLASMA KALLIKREIN AND BY PLASMIN - A REVISED METHOD OF PURIFICATION OF HIGH-MOLECULAR-WEIGHT KININOGEN
    KLENIEWSKI, J
    DONALDSON, VH
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1987, 109 (04): : 469 - 479
  • [8] Nitric oxide bioavailability is also regulated by the cGMP pathway in L-NAME hypertensive cardiomyopathy of rats.
    Ferreira-Melo, S
    Yugar-Toledo, JC
    Souza, WA
    Thomaz, AJ
    Franchini, KG
    Coelho, OR
    de Lucca, I
    Moreno, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P13 - P13
  • [9] Nitric oxide (NO) bioavailability is also regulated by cGMP pathway in L-NAME hypertensive cardiomyopathy in rats.
    Ferreira, SE
    Yugar, JC
    Souza, WA
    Thomaz, AJ
    Franchini, KG
    Coelho, OR
    de Lucca, IM
    Moreno, H
    JOURNAL OF HYPERTENSION, 2004, 22 : S34 - S34
  • [10] Increased calcium sensitivity and EDHF activity in the mesenteric bed of L-NAME hypertensive rats
    Ruiz, FM
    Fortepiani, L
    Ortiz, MC
    Janvier, JJ
    García-Estañ, J
    Atucha, NM
    JOURNAL OF HYPERTENSION, 1998, 16 : S84 - S84